Defu Li, Dejun Sun, Liang Yuan, Chunli Liu, Lingzhu Chen, Guihua Xu, Jiaze Shu, Ruijuan Guan, Jingyi Xu, Yuanyuan Li, Gao Yi, Hongwei Yao, Nanshan Zhong, Jian Wang, Wenju Lu
Exacerbation of chronic obstructive pulmonary disease (COPD) is characterized by acute airway inflammation and mucus hypersecretion, which is by far the most costly aspect of its management. Thus, it is essential to develop therapeutics with low side effects for CODP exacerbation. Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of tanshinone IIA isolated as the major active component of Chinese herbal medicine Danshen. Although it possesses anti-inflammatory, anti-oxidative and anti-apoptotic properties, it remains unknown whether STS protects against COPD exacerbation...
April 2020: International Immunopharmacology